amarantus, catabasis, chiasma, spherics, sarcode, histogen, kythera, nodality, calypte, intercell, nucleonics, artus, conatus, microphage, spiration, neogenesis, biotech, clavis, genova, immunotherapeutic, acrux, therapeutics, savara, biotechnology, ikaria, jarvik heart, cephalon, bionomics, lani, calando, monoclonal antibody, eyet, corixa, orthopoxvirus, auspex, brahms, respiratory syncytial virus, phase iii, ichor, chromos, neri, biodefence, idun, duros, ceftazidime, affy, proventil, phase iii clinical trial, capoten, medicago, mycobacterium tuberculosis, plaquenil, pharmaceutical, immune response, inflammatory disease, biodefense, sporanox, oncology, tenormin, quinacrine, diclofenac potassium, hemophilia b, angiogenesis inhibitor, primaxin, mab, phyton, immunology, imuran, replicon, allos, mesoblast, poniard, commercialization, cepheid, dihydrochloride, rpa, biogen, protozoal, albert sabin, immunogenetics, benzimidazole, retrovir, reverse transcriptase inhibitor, idiopathic thrombocytopenic purpura, immunomodulator, piperacillin, lymphogranuloma venereum, zeatin, versant, aveo, alveolus, sulfamethoxazole, activase, tyrosine kinase inhibitor, creon, monoclonal, rommel, forerun, proteomics, fluxion, adoxa, maleate

aftermath, consequence